| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Antiphospholipid antibody syndrome | 138 | 8 | |
| Deep vein thrombosis | 102 | 14 | |
| Prevent blood clotting | 49 | 21 | |
| Pulmonary embolism | 16 | 7 | |
| Blood clot | 11 | 7 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Bruising | 9 | |
| Injection site bruising | 5 | |
| Injection site pain | 4 | |
| Nosebleeds (epistaxis) | 2 | |
| Bleed easily | 1 | |
| Bone pain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 4 | |
| Moderate | 12 | |
| Mild | 16 | |
| None | 21 |
Member evaluations
SoreMomma
evaluated on Mar 16, 2014
- Perceived effectiveness for pulmonary embolism: Major
- Side effects: Moderate
Tom M
evaluated on Jul 27, 2011
- Perceived effectiveness for blood clot: Can't tell
- Side effects: Mild
JnSma6
evaluated on Apr 20, 2010
- Perceived effectiveness for blood clot: Major
- Side effects: Mild